New Market Study Published: Jordan Pharmaceuticals & Healthcare Report Q3 2010

June 5, 2010 - PRLog -- The Jordan Association of Pharmaceutical Manufacturers states that the pharmaceutical sector in Jordan is export driven, which a glance at the trade balance confirms. There are 17 local pharmaceutical firms - the result of major consolidation (M&A) in the Jordanian drug sector. Around 81% of output is exported to over 60 countries. This does not mean that there is little to be gained from the local market, but it does underline that exports are expected to continue rising in the medium term.

BMI expects the total pharmaceutical market to increase from US$397mn in 2009 to US$531mn by 2014 at a CAGR of 6% in US dollar terms. By this time, per-capita drug expenditure in Jordan will reach US$73.70 while 1.7% of GDP will be attributed to pharmaceutical spending

Jordan has long been a medical tourism centre for the Middle East and the latest announcement from the Private Hospitals Association (PHA) revealed that there has been a 10% rise in patients during 2009, with Iraqis listed as the highest proportion of foreign citizens to visit the Kingdom. In line with our long-term view, Jordan fulfils the criteria of being politically stable, having a cost-effective healthcare system and an established tourism sector in which to leverage medical tourism.

Since Iraq's healthcare system is in total disarray, the presence of its citizens is relatively unsurprising. More telling is the fact that Saudi Arabian patients are also heading for Jordan - particularly after a recent report in Zawya revealed that the Saudi government is promoting medical tourism within its own borders, stressing that its private healthcare sector is sufficiently advanced. BMI maintains its view that Jordan will continue to attract citizens from its Arab neighbours for medical treatment and that this forms a strong basis for growth in private healthcare expenditure in the country.

The Jordanian medical tourism sector has several advantages over the younger Saudi version. Its maturity and therefore reputation will continue to attract tourists, while the country itself is known for being a holiday destination owing to its comparatively liberal laws. Therefore, Jordan attracts both Arab and non- Arab tourists looking for cheaper healthcare. Moreover, the promotion and marketing of the Jordanian healthcare sector is more advanced than the Saudi equivalent, largely because around US$1bn worth of revenues contributes to the Jordanian economy every year. While the rise of Tunisian medical tourism could be argued to provide some competition for Jordan, rather than Saudi Arabia, we note that related tourism areas including travel agencies have streamlined connections from airports to hotels and hospitals, making Jordan the more attractive option.

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/65636_jordan_pharmaceuticals_h...

Report Table of Contents:

Executive Summary
SWOT Analysis
- Jordan Pharmaceuticals And Healthcare Industry SWOT
- Jordan Political SWOT
- Jordan Economic SWOT
- Jordan Business Environment Industry SWOT
Pharmaceutical Business Environment Ratings
- Table: Middle East And Africa (MEA) - Regional Pharmaceutical Business Environment Ratings for Q310
- Limits to Potential Returns
- Risks to Realisation Of Returns
Jordan - Market Summary
Regulatory Regime
- Recent Regulatory Developments
- Intellectual Property Regime
- Recent IP Developments
- Counterfeit Pharmaceuticals
- Public Sector Procurement of Medicines
- Pricing And Reimbursement Issues
- Recent Pricing And Reimbursement Developments
- International Collaboration
- Recent International Collaboration Developments
Industry Developments
- Epidemiology
- Healthcare Sector
- Recent Healthcare Sector Developments
- Healthcare Insurance
- Medical Tourism
- Retail Pharmacy Sector
- Research and Development Sector
- Biotechnology
- Clinical Trials
- Medical Devices
Industry Forecast Scenario
- Overall Market Forecasts
- Key Growth Factors - Industry
- Macroeconomic Forecast
- Table: Jordan Economic Activity
- Prescription Drug Market Forecast
- Patented Product Market Forecast
- Generic Drug Market Forecast
- OTC Medicine Market Forecast
- Medical Device Market Forecast
- Pharmaceutical Trade Forecast
- Other Healthcare Data Forecasts
- Key Risks To BMI's Forecasts
Competitive Landscape
- Pharmaceutical Industry
- Table: Jordan - Leading Pharmaceutical Companies, By Value
- Table: Jordan - Leading Pharmaceutical Companies in the Branded Market, by Value
- Domestic Pharmaceuticals Sector
- Recent Domestic Company Activities
- Foreign Companies
Company Monitor
- Indigenous Manufacturers
- Pharma International Company
- Arab Pharmaceutical Manufacturers (APM)
- Dar Al Dawa (DAD)
- Hikma Pharmaceuticals
- Jordanian Pharmaceutical Manufacturing (JPM)
- United Pharmaceutical Manufacturers
- Multinational Companies
- Pfizer
- GlaxoSmithKline
- Novartis
- Sanofi-Aventis
- Merck & Co
Country Snapshot: Jordan Demographic Data
- Section 1: Population
- Table: Demographic Indicators, 2005-2030
- Table: Rural/Urban Breakdown, 2005-2030
- Section 2: Education And Healthcare
- Table: Education, 2002-2005
- Table: Vital Statistics, 2005-2030
- Section 3: Labour Market And Spending Power
- Table: Consumer Expenditure, 2000-2012
- Table: Average Annual Manufacturing Wages, 2000-2012
BMI Methodology
- How We Generate Our Pharmaceutical Industry Forecasts
- Pharmaceutical Business Environment Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources
Forecast Tables

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.  BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports.  Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports.  View more research from Business Monitor International at http://www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.